Au, Wing-Yan <br/><br/>
Alemtuzumab induced complete remission of therapy-resistant pure red cell aplasia.  [electronic resource] 

 -  Leukemia research  Oct 2005 
 - 1213-5 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>0145-2126 
<br/><br/><label>Standard No.: </label>10.1016/j.leukres.2005.02.018  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Alemtuzumab<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Humanized<br/>Antibodies, Neoplasm--therapeutic use<br/>Antilymphocyte Serum--administration & dosage<br/>Antineoplastic Agents--therapeutic use<br/>Cyclophosphamide--administration & dosage<br/>Cyclosporine--administration & dosage<br/>Dexamethasone--administration & dosage<br/>Drug Resistance, Neoplasm<br/>Humans<br/>Leukemia, T-Cell--complications<br/>Male<br/>Mitoxantrone--administration & dosage<br/>Prednisolone--administration & dosage<br/>Red-Cell Aplasia, Pure--complications<br/>Remission Induction<br/>Vidarabine--administration & dosage